Cita APA (7a ed.)
Sartaj, A., Annu, Biswas, L., Verma, A. K., Sahoo, P. K., Baboota, S., & Ali, J. (2022, February 3). Ribociclib Nanostructured Lipid Carrier Aimed for Breast Cancer: Formulation Optimization, Attenuating In Vitro Specification, and In Vivo Scrutinization. BioMed Research International, 1-25.
Cita Chicago Style (17a ed.)
Sartaj, Ali, Annu, Largee Biswas, Anita Kamra Verma, P. K. Sahoo, Sanjula Baboota, y Javed Ali. "Ribociclib Nanostructured Lipid Carrier Aimed for Breast Cancer: Formulation Optimization, Attenuating In Vitro Specification, and In Vivo Scrutinization." BioMed Research International 3 Feb. 2022: 1-25.
Cita MLA (9a ed.)
Sartaj, Ali, et al. "Ribociclib Nanostructured Lipid Carrier Aimed for Breast Cancer: Formulation Optimization, Attenuating In Vitro Specification, and In Vivo Scrutinization." BioMed Research International, 3 Feb. 2022, pp. 1-25.
Precaución: Estas citas no son 100% exactas.